Amyloid beta accumulation in HIV‐1‐infected brain: The role of the blood brain barrier

No abstract is available for this paper.

• Publication year

  2013

• Venue

  IUBMB Life - A Journal of the International Union of Biochemistry and Molecular Biology

• Publication date

  2013-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/iub.1106PMID 23225609PMCID PMC3804005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

  2013cited by this paper
• Altered Distribution of the Gangliosides GM1 and GM2 in Alzheimer’s Disease

  2012cited by this paper
• Lipid rafts and functional caveolae regulate HIV-induced amyloid beta accumulation in brain endothelial cells.

  2012cited by this paper
• Clusterin mRNA and Protein in Alzheimer's Disease

  2012cited by this paper
• HIV-1 gp120-Induced Axonal Injury Detected by Accumulation of β-Amyloid Precursor Protein in Adult Rat Corpus Callosum

  2011cited by this paper
• Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice.

  2011cited by this paper
• LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.

  2011cited by this paper
• Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders

  2011cited by this paper
• O1‐07‐04: Blood‐brain barrier p‐glycoprotein function in Alzheimer's disease

  2011cited by this paper
• Advanced Glycation End Products Inhibit Both Infection and Transmission In Trans of HIV-1 from Monocyte-Derived Dendritic Cells to Autologous T Cells

  2011influential reference
• Changes in Brain &bgr;-Amyloid Deposition and Aquaporin 4 Levels in Response to Altered Agrin Expression in Mice

  2011cited by this paper
• Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain

  2010cited by this paper
• Circulating neprilysin clears brain amyloid.

  2010cited by this paper
• Amyloid Efflux Transporter Expression at the Blood-Brain Barrier Declines in Normal Aging

  2010cited by this paper
• Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer's Disease

  2010cited by this paper
• HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin.

  2010cited by this paper
• HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures.

  2010cited by this paper
• The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART Era

  2009influential reference
• P-Glycoprotein and Breast Cancer Resistance Protein Restrict Apical-to-Basolateral Permeability of Human Brain Endothelium to Amyloid-β

  2009cited by this paper
• Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease

  2009cited by this paper
• Testing the Neurovascular Hypothesis of Alzheimer's Disease: LRP-1 Antisense Reduces Blood-brain Barrier Clearance, Increases Brain Levels of Amyloid-β Protein, and Impairs Cognition

  2009cited by this paper
• ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40 Peptides

  2009cited by this paper
• Amyloid β Interaction with Receptor for Advanced Glycation End Products Up-Regulates Brain Endothelial CCR5 Expression and Promotes T Cells Crossing the Blood-Brain Barrier1

  2009cited by this paper
• HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice.

  2009influential reference
• Agrin, Aquaporin-4, and Astrocyte Polarity as an Important Feature of the Blood-Brain Barrier

  2009cited by this paper
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes

  2009cited by this paper
• Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer’s disease

  2009cited by this paper
• Growing old with HIV: The AIDS epidemic and an aging population

  2009cited by this paper
• SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells

  2009cited by this paper
• HIV Regulation of Amyloid Beta Production

  2009cited by this paper
• Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients

  2009cited by this paper
• Site-Specific Blockade of RAGE-Vd Prevents Amyloid-β Oligomer Neurotoxicity

  2008cited by this paper
• Simvastatin Protects against Amyloid β and HIV-1 Tat-Induced Promoter Activities of Inflammatory Genes in Brain Endothelial Cells

  2008cited by this paper
• Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

  2008cited by this paper
• Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases

  2008cited by this paper
• Caveolin-1 Regulates Human Immunodeficiency Virus-1 Tat-Induced Alterations of Tight Junction Protein Expression via Modulation of the Ras Signaling

  2008cited by this paper
• New therapeutic targets in the neurovascular pathway in Alzheimer’s disease

  2008cited by this paper
• Statins and the vascular endothelial inflammatory response.

  2007cited by this paper
• Clearance of amyloid-beta by circulating lipoprotein receptors.

  2007cited by this paper
• Lipid rafts in health and disease

  2007cited by this paper
• Internalization of β-Amyloid Peptide by Primary Neurons in the Absence of Apolipoprotein E*

  2007cited by this paper
• Clearance of amyloid-β by circulating lipoprotein receptors

  2007cited by this paper
• Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions

  2006cited by this paper
• Key Role of Src Kinase in S100B-induced Activation of the Receptor for Advanced Glycation End Products in Vascular Smooth Muscle Cells*

  2006cited by this paper
• Signaling Mechanisms of HIV-1 Tat-Induced Alterations of Claudin-5 Expression in Brain Endothelial Cells

  2005cited by this paper
• GM1 Ganglioside and the Seeding of Amyloid in Alzheimer’s Disease: Endogenous Seed for Alzheimer Amyloid

  2005cited by this paper
• Cell death in HIV dementia

  2005cited by this paper
• HIV-1 Tat inhibits neprilysin and elevates amyloid β

  2005cited by this paper
• Neurovascular mechanisms of Alzheimer's neurodegeneration.

  2005cited by this paper
• P3-371 HIV-1 TAT inhibits neprilysin and elevates amyloid beta

  2004cited by this paper
• RAGE (Yin) Versus LRP (Yang) Balance Regulates Alzheimer Amyloid &bgr;-Peptide Clearance Through Transport Across the Blood–Brain Barrier

  2004cited by this paper
• Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease.

  2004cited by this paper
• Higher frequency of dementia in older HIV-1 individuals

  2004cited by this paper
• Altered P‐Glycoprotein Expression in AIDS Patients with HIV Encephalitis

  2004cited by this paper
• Modulation of the LDL receptor and LRP levels by HIV protease inhibitors Published, JLR Papers in Press, July 7, 2003. DOI 10.1194/jlr.M200487-JLR200

  2003cited by this paper
• HIV‐1 gp120 induces anergy in naive T lymphocytes through CD4‐independent protein kinase‐A‐mediated signaling

  2003cited by this paper
• Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model

  2003cited by this paper
• RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

  2003influential reference
• The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis.

  2002cited by this paper
• Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier.

  2000cited by this paper
• Mononuclear phagocytes mediate blood‐brain barrier compromise and neuronal injury during HIV‐1‐associated dementia

  2000cited by this paper
• Prevalence of Alzheimer plaques in AIDS

  1998cited by this paper
• Accumulation of β‐amyloid precursor protein in HIV encephalitis: Relationship with neuropsychological abnormalities

  1997cited by this paper
• Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.

  1996cited by this paper
• Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease

  1994cited by this paper
• Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method.

  1990cited by this paper
• Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

  1986cited by this paper

• Kisspeptin-10 Protects Against HIV-1 Tat-Induced Blood-Brain Barrier Dysfunction and Neuroinflammation via RhoA/ROCK Pathway: Implications for HAND Therapy.

  2025cites this paper
• HIV-Tat and vascular endothelium: implications in the HIV associated brain, heart, and lung complications

  2025cites this paper
• α-Synuclein fibrils enhance HIV-1 infection of human T cells, macrophages and microglia

  2025cites this paper
• Autoantibody-mediated disorders of the central and peripheral nervous system: Overview Infection.

  2025cites this paper
• HIV-1 Tat-Mediated Human Müller Glial Cell Senescence Involves Endoplasmic Reticulum Stress and Dysregulated Autophagy

  2024cites this paper
• HIV-Associated Neurocognitive Disorder (HAND) and Alzheimer’s Disease Pathogenesis: Future Directions for Diagnosis and Treatment

  2024cites this paper
• Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management

  2023cites this paper
• Alzheimer-Type Cerebral Amyloidosis in the Context of HIV Infection: Implications for a Proposed New Treatment Approach

  2023cites this paper
• Methamphetamine Dysregulates Macrophage Functions and Autophagy to Mediate HIV Neuropathogenesis

  2022cites this paper
• Morphine disrupts macrophage functions even during HIV infection

  2022cites this paper
• Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp120

  2021cites this paper
• Alzheimer’s-Like Pathology at the Crossroads of HIV-Associated Neurological Disorders

  2021cites this paper
• Photoelectrochemical Detection of β-amyloid Peptides by a TiO2 Nanobrush Biosensor

  2020cites this paper
• Oligomer β-amyloid Induces Hyperactivation of Ras to Impede NMDA Receptor-Dependent Long-Term Potentiation in Hippocampal CA1 of Mice

  2020cites this paper
• Physicochemical Insights into Role of Drug Functionality in Fibrillation Inhibition of Bovine Serum Albumin.

  2020cites this paper
• Endoplasmic reticulum stress and autophagy in HIV-1-associated neurocognitive disorders

  2020cites this paper
• Pharmacological Inhibition of Amyloidogenic APP Processing and Knock-Down of APP in Primary Human Macrophages Impairs the Secretion of Cytokines

  2020cites this paper
• Heme attenuates beta-endorphin levels in leukocytes of HIV positive individuals with chronic widespread pain

  2020cites this paper
• Intersecting roles of ER stress, mitochondrial dysfunction, autophagy, and calcium homeostasis in HIV-associated neurocognitive disorder

  2020cites this paper
• Anti-HIV drugs promote β-amyloid deposition and impair learning and memory in BALB/c mice

  2020cites this paper
• Heme Attenuates Endogenous Opioid Levels in Leukocytes of HIV positive individuals with Chronic Widespread Pain

  2020influential citation
• HIV‐1 infection and latency‐reversing agents bryostatin‐1 and JQ1 disrupt amyloid beta homeostasis in human astrocytes

  2020cites this paper
• Alzheimer's disease-like perturbations in HIV-mediated neuronal dysfunctions: understanding mechanisms and developing therapeutic strategies

  2020cites this paper
• Pharmacological inhibition of APP processing and knock-down of APP in primary human macrophages impairs the secretion of cytokines

  2019cites this paper
• Signatures of HIV-1 subtype B and C Tat proteins and their effects in the neuropathogenesis of HIV-associated neurocognitive impairments.

  2019cites this paper
• Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern

  2019cites this paper
• In Silico Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts

  2019cites this paper
• HIV Infection Induces Extracellular Cathepsin B Uptake and Damage to Neurons

  2019cites this paper
• HIV and Alzheimer’s disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein

  2019influential citation
• Role of Withaferin A as a Neuroprotectant against Beta Amyloid Induced Toxicity and associated mechanism

  2019cites this paper
• The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease

  2019cites this paper
• Role of Cav-1 in HIV-1 Tat-Induced Dysfunction of Tight Junctions and Aβ-Transferring Proteins

  2019cites this paper
• Cognitive Impairment in people living with HIV in the ART era: A Review

  2018cites this paper
• Neprilysin in the Cerebrospinal Fluid and Serum of Patients Infected With HIV1-Subtypes C and B

  2018cites this paper
• Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C

  2018cites this paper
• Structural discordance in HIV-1 Vpu from brain isolate alarms amyloid fibril forming behavior- a computational perspective.

  2018cites this paper
• Alterations in brain TREM2 and Amyloid‐β levels are associated with neurocognitive impairment in HIV‐infected persons on antiretroviral therapy

  2018cites this paper
• HIV Neuroinfection and Alzheimer’s Disease: Similarities and Potential Links?

  2018cites this paper
• Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions

  2018cites this paper
• "APP"reciating the complexity of HIV-induced neurodegenerative diseases

  2018cites this paper
• Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study

  2017cites this paper
• Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner

  2017cites this paper
• HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration

  2017cites this paper
• Microwave & magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment

  2017cites this paper
• Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer’s Disease: an Emerging Issue in Geriatric NeuroHIV

  2017cites this paper
• Alpha7 nicotinic acetylcholine receptor is required for amyloid pathology in brain endothelial cells induced by Glycoprotein 120, methamphetamine and nicotine

  2017cites this paper
• HIV-1-associated inflammation and antiretroviral therapy regulate astrocyte endoplasmic reticulum stress responses

  2017cites this paper
• Complexity across scales: a walkthrough to linking neuro-imaging readouts to molecular processes

  2017influential citation
• HIV-1 Transactivator Protein Induces ZO-1 and Neprilysin Dysfunction in Brain Endothelial Cells via the Ras Signaling Pathway

  2017cites this paper
• An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition

  2016cites this paper
• HIV-1 gp120 induces type-1 programmed cell death through ER stress employing IRE1α, JNK and AP-1 pathway

  2016cites this paper
• Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity

  2016cites this paper
• Nano-biosensors to detect beta-amyloid for Alzheimer's disease management.

  2016cites this paper
• Viral capsid assembly as a model for protein aggregation diseases: Active processes catalyzed by cellular assembly machines comprising novel drug targets.

  2015cites this paper
• Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.

  2015cites this paper
• Amyloid beta-42 (Aβ-42), neprilysin and cytokine levels. A pilot study in patients with HIV related cognitive impairments.

  2015cites this paper
• On Cerebrosp inal Fluid Biomarkers of HIV-1 I nfection

  2015cites this paper
• Blood-brain barrier and neuro-AIDS.

  2015cites this paper
• MOL098590 304..315

  2015cites this paper
• On cerebrospinal fluid biomarkers of HIV-1 infection

  2015cites this paper
• Dysregulation of Endoplasmic Reticulum Stress and Autophagic Responses by the Antiretroviral Drug Efavirenz

  2015cites this paper
• HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?

  2015cites this paper
• Role of HIV in Amyloid Metabolism

  2014cites this paper
• Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users

  2014cites this paper
• Amyloid beta accumulation in HIV-1 infected brain: the role of altered cholesterol homeostasis.

  2014cites this paper
• Novel Role of Mannose Binding Lectin in Neuroinflammation and Neurocognitive Consequences in HIV-1 Infected Brain /

  2014cites this paper